United States · FDA National Drug Code directory
ALDURAZYME
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58468-0070_c37ec1bf-5497-45ca-a204-915b91bff0f6
- Product NDC
- 58468-0070
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- laronidase
- Labeler
- Genzyme Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20030430
- Source listing expiry
- 20271231
Source-listed ingredients
- LARONIDASE — 2.9 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 VIAL, GLASS (58468-0070-1) · 58468-0070-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →